BHMT

Across TCGA pan-cancer cohorts, BHMT Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated BHMT data layer compared with 22 for mass-spec protein and 3 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher BHMT Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated BHMT expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

ESCA and UCEC are the cancer types where BHMT Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	II,III,IV	0.216	0.702	.014	6	view →
UCEC	DFS	Median	All	0.958	0.620	.022	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

BHMT–ESCA (OS)

Open the ESCA breakdown →